Concomitant major vessel resection in pancreatic adenocarcinoma

References

• Ansari D, Chen BC, Dong L, Zhou MT, Andersson R. Pancreatic cancer: translational research aspects and clinical implications. World J Gastroenterol 2012;18:1417–24
   Web of Science ®Google Scholar
• Strobel O, Berens V, Hinz U, Hartwig W, Hackert T, Bergmann F, et al. Resection after neoadjuvant therapy for locally advanced, “unresectable” pancreatic cancer. Surgery 2012;152:S33–42
   Google Scholar
• Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228:508–17
   PubMed Web of Science ®Google Scholar
• Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229:613–22; discussion 22–4
   Google Scholar
• Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138:618–28; discussion 28–30
   PubMed Web of Science ®Google Scholar
• Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 2012;19:230–41
   Google Scholar
• Cheung TT, Poon RT, Chok KS, Chan AC, Tsang SH, Dai WC, et al. Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability. World J Gastroenterol 2014;20:17448–55
   Google Scholar
• Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 2011;254:882–93
   PubMed Web of Science ®Google Scholar
• Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B, et al. Arterial resection at the time of pancreatectomy for cancer. Surgery 2014;155:919–26
   Google Scholar
• Marangoni G, O’Sullivan A, Faraj W, Heaton N, Rela M. Pancreatectomy with synchronous vascular resection--an argument in favour. Surgeon 2012;10:102–6
   Google Scholar
• Sgroi MD, Narayan RR, Lane JS, Demirjian A, Kabutey NK, Fujitani RM, Imagawa DK. Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma. J Vasc Surg 2015;61:475–80
   Google Scholar
• Ravikumar R, Holroyd D, Fusai G. Is there a role for arterial reconstruction in surgery for pancreatic cancer? World J Gastrointest Surg 2013;5:27–9
   Google Scholar
• Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB3rd, Casper ES, et al. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2012;10:703–13
   PubMed Web of Science ®Google Scholar
• Tucker ON, Rela M. Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement. HPB Surg 2008;2008:839503
   PubMedGoogle Scholar
• Sho M, Akahori T, Tanaka T, Kinoshita S, Tamamoto T, Nomi T, et al. Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer. J Hepatobiliary Pancreat Sci 2013;20:197–205
   PubMed Web of Science ®Google Scholar
• Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 2006;13:1035–46
   PubMed Web of Science ®Google Scholar
• Dudeja V, Greeno EW, Walker SP, Jensen EH. Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression. HPB 2013;15:661–7
   Google Scholar
• Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014;155:977–88
   PubMed Web of Science ®Google Scholar
• Yu XZ, Li J, Fu DL, Di Y, Yang F, Hao SJ, Jin C. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis. Eur J Surg Oncol 2014;40:371–8
   PubMed Web of Science ®Google Scholar
• Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 2008;247:300–9
   PubMed Web of Science ®Google Scholar
• Nakao A, Takeda S, Inoue S, Nomoto S, Kanazumi N, Sugimoto H, Fujii T. Indications and techniques of extended resection for pancreatic cancer. World J Surg 2006;30:976–82; discussion 83-4
   Google Scholar
• Ishikawa O, Ohigashi H, Imaoka S, Furukawa H, Sasaki Y, Fujita M, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992;215:231–6
   PubMedGoogle Scholar
• Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas EF, Izbicki JR. Arterial en bloc resection for pancreatic carcinoma. Br J Surg 2011;98:86–92
   PubMedGoogle Scholar
• Mellon EA, Hoffe SE, Springett GM, Frakes JM, Strom TJ, Hodul PJ, et al. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma. Acta Oncol 2015. [Epub ahead of print]
   Google Scholar
• Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H, Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 2010;7:e1000267
   PubMed Web of Science ®Google Scholar
• Heinemann V, Haas M, Boeck S. Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer. Ann Oncol 2013;24:2484–92
   PubMed Web of Science ®Google Scholar
• Rose JB, Rocha FG, Alseidi A, Biehl T, Moonka R, Ryan JA, et al. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival. Ann Surg Oncol 2014;21:1530–7
   Google Scholar
• He J, Page AJ, Weiss M, Wolfgang CL, Herman JM, Pawlik TM. Management of borderline and locally advanced pancreatic cancer: where do we stand? World J Gastroenterol 2014;20:2255–66
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ishikura H, Motohara T, Okushiba S, Dohke M, Katoh H. Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 1997;65:164–70
   PubMed Web of Science ®Google Scholar
• Takahashi S, Hasebe T, Oda T, Sasaki S, Kinoshita T, Konishi M, et al. Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma. Anticancer Res 2001;21:1407–12
   Google Scholar
• Hirano S, Kondo S, Hara T, Ambo Y, Tanaka E, Shichinohe T, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg 2007;246:46–51
   PubMed Web of Science ®Google Scholar
• Miura T, Hirano S, Nakamura T, Tanaka E, Shichinohe T, Tsuchikawa T, et al. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study. Surgery 2014;155:457–67
   Google Scholar
• Yi SQ, Miwa K, Ohta T, Kayahara M, Kitagawa H, Tanaka A, et al. Innervation of the pancreas from the perspective of perineural invasion of pancreatic cancer. Pancreas 2003;27:225–9
   PubMed Web of Science ®Google Scholar
• Zhou YM, Zhang XF, Li XD, Liu XB, Wu LP, Li B. Distal pancreatectomy with en bloc celiac axis resection for pancreatic body-tail cancer: is it justified? Med Sci Monit 2014;20:1–5
   Google Scholar
• Yamamoto Y, Sakamoto Y, Ban D, Shimada K, Esaki M, Nara S, Kosuge T. Is celiac axis resection justified for T4 pancreatic body cancer? Surgery 2012;151:61–9
   Google Scholar
• Takahashi Y, Kaneoka Y, Maeda A, Isogai M. Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas. World J Surg 2011;35:2535–42
   PubMed Web of Science ®Google Scholar
• Okada K, Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, et al. Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery 2013;153:365–72
   Google Scholar
• Hirono S, Yamaue H. Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection. J Hepatobiliary Pancreat Sci 2015;22:E4–7
   Google Scholar
• Okada K, Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, et al. Preservation of the left gastric artery on the basis of anatomical features in patients undergoing distal pancreatectomy with celiac axis en-bloc resection (DP-CAR). World J Surg 2014;38:2980–5
   Google Scholar
• Kato K, Kondo S, Hirano S, Tanaka E, Shichinohe T, Tsuchikawa T, Matsumoto J. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy. J Hepatobiliary Pancreat Sci 2011;18:712–16
   Google Scholar
• Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, et al. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer 2012;118:3182–90
   PubMed Web of Science ®Google Scholar
• Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R, et al. Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann Diagn Pathol 2012;16:29–37
   PubMed Web of Science ®Google Scholar
• Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007;297:267–77
   PubMed Web of Science ®Google Scholar
• Satoi S, Yamaue H, Kato K, Takahashi S, Hirono S, Takeda S, et al. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2013;20:590–600
   Google Scholar